Serc
In brief
- In our pharmacy, you can buy Serc without a prescription, with delivery across Australia in 3–14 days and discreet packaging available.
- Serc (betahistine) is used to treat Ménière’s disease and other causes of vertigo; it is a histamine analogue that acts mainly as an H1 agonist and H3 antagonist to improve inner‑ear microcirculation and vestibular function.
- The usual dose is 16 mg two to three times daily or 24 mg twice daily, with a typical maximum of 48 mg per day; dosing may be adjusted by a clinician according to response and tolerability.
- Administered orally as tablets (commonly 8 mg, 16 mg or 24 mg; film‑coated tablets in blister packs or boxes).
- Some patients notice symptomatic improvement within a few days, but beneficial effects often develop gradually over several weeks.
- The effect of an individual dose typically lasts several hours; sustained clinical benefit generally requires regular daily dosing and may continue while treatment is maintained.
- Avoid or limit alcohol while taking Serc — alcohol can worsen vertigo and may increase drowsiness or gastrointestinal side effects.
- The most common side effects are gastrointestinal disturbances (nausea, dyspepsia, stomach pain) and headache; allergic skin reactions and mild drowsiness can also occur.
- Would you like to try serc without a prescription?
Critical Warnings & Restrictions (Safety First)
Basic Serc Information
- INN (International Nonproprietary Name): Betahistine
- Brand Names Available In Australia: Serc (available in 16 mg and 24 mg formulations)
- ATC Code: N07CA01
- Forms & Dosages: Tablets 8 mg, 16 mg, 24 mg — oral, commonly supplied in blister packs or boxes
- Manufacturers In Australia: not specified
- Registration Status In Australia: Approved for prescription use (TGA-registered)
- OTC / Rx Classification: Prescription-only (Rx)
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Patients ask, “Is this safe for me if I’m older, pregnant or have long‑term health issues?”
Betahistine is prescription-only and must be used with care in high-risk groups.
Absolute contraindications include known hypersensitivity, pheochromocytoma and pregnancy; many national guidelines advise against use in pregnancy.
Relative precautions apply for people with bronchial asthma, active peptic ulcer disease and significant cardiovascular disease.
For older patients and those with hepatic impairment, consider lower initial doses and close monitoring.
- Checklist for monitoring and screening: record allergy history and prior drug reactions.
- Checklist for monitoring and screening: perform a pregnancy test if the patient could be pregnant.
- Checklist for monitoring and screening: review current asthma therapies, peptic ulcer history and cardiovascular medications.
- Checklist for monitoring and screening: check renal and hepatic status and document baseline function.
- Checklist for monitoring and screening: schedule follow-up contact within 2–4 weeks to assess tolerability and effect.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
People worry about driving or working shifts while starting a new vertigo medication.
Betahistine can cause dizziness or mild drowsiness in some people, so advise caution until individual response is known.
Document counselling in pharmacy notes for medico‑legal safety and to assist the prescriber with follow-up.
- Counselling points: warn patients not to drive or operate heavy machinery until they know how betahistine affects them.
- Counselling points: advise avoiding safety-sensitive work during the first days of treatment or after dose changes.
- Counselling points: suggest avoiding alcohol until tolerance is established because alcohol may worsen vertigo and sedation.
- Counselling points: ask the employer to allow modified duties if workplace safety is affected, and document the advice.
- Counselling points: record the discussion in the patient’s pharmacy file, noting date and key points.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Not until you know how the medicine affects you.
- Stop driving or operating machinery if you experience dizziness or drowsiness.
- Seek advice from your GP or pharmacist if symptoms persist or worsen.
- Report to your employer if your ability to perform safety‑sensitive work is affected.
Usage Basics
INN And Brand Names Available In Australia
Many people ask, “What brand will my GP prescribe?”
- INN
- Betahistine
- Common Brands
- Serc (commonly available in Australia)
- Available Strengths
- 8 mg, 16 mg, 24 mg tablets — Serc commonly in 16 mg and 24 mg
Legal Classification (TGA‑Approved, PBS Status)
Is betahistine subsidised on the PBS?
Betahistine is TGA‑registered and prescription-only in Australia.
PBS subsidy status can vary by formulation and indication; check the PBS Schedule or ARTG entry before assuming subsidy.
Pharmacies must supply on a valid prescription; lawful electronic prescriptions and telehealth scripts are accepted.
| TGA Status | PBS Listed? | Prescription Required |
|---|---|---|
| Registered For Prescription Use | Confirm (varies by product/indication) | Yes |
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Patients commonly ask, “How many times a day should I take it?”
- Common starting regimens: 16 mg two to three times daily.
- Alternative regimen: 24 mg twice daily is also commonly cited.
- Maximum commonly cited daily dose: 48 mg.
- Treatment duration: weeks to months for Ménière’s disease or chronic vestibular symptoms; improvement can be gradual.
Adjustments For Comorbidities
What if the patient is a child, elderly or has kidney/liver problems?
Children: not generally recommended because safety and efficacy data are insufficient.
Elderly: use caution, monitor comorbidities and renal/hepatic function; individualise dosing.
Renal or hepatic impairment: limited specific data — consider a lower starting dose and monitor response closely.
- Monitoring checklist: monitor blood pressure and signs of postural hypotension.
- Monitoring checklist: watch for gastrointestinal symptoms such as nausea or dyspepsia.
- Monitoring checklist: monitor for worsening asthma symptoms or bronchospasm if relevant.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless it is near the next scheduled dose.
Do not double up doses to make up for a missed one.
If missed doses become frequent and affect symptom control, review adherence with your pharmacist or GP and consider dose scheduling aids.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Patients often ask whether their coffee or weekend beer will interfere.
Alcohol can worsen vertigo and may increase drowsiness; avoid or limit alcohol while assessing tolerance to betahistine.
No strong food–drug interactions are documented, but heavy caffeine intake may exacerbate inner‑ear symptoms in some people.
- Avoid alcohol during dose initiation and if dizziness or sedation occurs.
- Consider cutting back on strong coffee if it seems to worsen vestibular symptoms.
- Maintain a balanced diet and stay hydrated to help overall symptom control.
Common Drug Conflicts
Clinically important interactions are limited but vigilance is required with certain drug classes.
| Drug Class | Likely Effect | Clinical Action |
|---|---|---|
| Antihypertensives | Possible additive vasodilatory/hypotensive effect | Monitor blood pressure; counsel on lightheadedness |
| CNS Depressants (e.g. sedatives) | Increased sedation/drowsiness | Advise caution with driving; consider dose timing |
| Drugs That Exacerbate Peptic Disease | Worsening GI symptoms | Monitor for dyspepsia; take with food if needed |
Always check current interaction references and perform a full medication reconciliation with the pharmacist.
User Reports & Trends (Australian Patient Voice)
Patients ask, “Does it work for most people with Ménière’s?”
Australian feedback from product review sites, health forums and pharmacy surveys shows variable response.
Many patients report symptom reduction over several weeks for Ménière’s and chronic vestibular vertigo.
Other patients report minimal benefit; individual response is variable.
Common adverse reports align with registry data: gastrointestinal upset, headache, mild drowsiness and occasional skin reactions.
- Top reported positives: reduction in attack frequency, improved daily functioning, fewer severe vertigo spells.
- Top reported negatives: lingering nausea or dyspepsia, headache, variable efficacy and access or cost concerns.
- Access notes: rural patients commonly report delays and occasional difficulty obtaining specific brands.
Suggested short table to collate patient ratings by source: ProductReview, health forums, pharmacy surveys — include sample size and mean satisfaction score.
Access & Purchase Options (Australia)
Major Retail Chains And Community Pharmacies
Where can patients get a supply after the GP prescribes it?
Serc and other betahistine brands are supplied on prescription via community pharmacies such as Chemist Warehouse, Priceline and TerryWhite Chemmart, as well as independent pharmacies.
Availability varies by store and region; wholesalers typically supply urban centres faster than remote or rural stores.
- Patient actions to secure supply: confirm the brand and strength with your prescriber before presentation to the pharmacy.
- Patient actions to secure supply: call ahead to check stock at your local pharmacy to avoid wasted trips.
- Patient actions to secure supply: consider asking the pharmacist about generic options or alternative brands if preferred strength is out of stock.
Online Pharmacies And Telehealth E‑Prescriptions
Can you order from an online pharmacy with a telehealth script?
Lawful e‑prescriptions and telehealth prescriptions are accepted by Australian pharmacies that are properly registered.
Online pharmacies may dispense on presentation of a valid electronic or scanned prescription; confirm the pharmacy is registered and reputable.
- Steps for ordering online: upload or present a valid prescription, confirm delivery address and expected delivery time, and request discreet packaging if preferred.
- Documentation required: valid electronic prescription or scanned hard copy and photo ID if requested by the pharmacy.
- Emergency refill options: ask your local pharmacist about emergency supply rules and whether the prescriber can fax or re-issue a script.
In our online pharmacy, serc is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism & Pharmacology
Simplified Explanation
Patients ask, “How does it help inner‑ear vertigo?”
Betahistine is thought to act as a histamine H1 receptor agonist and an H3 receptor antagonist.
These actions are believed to improve microcirculation in the inner ear and to modify vestibular neurotransmission.
The effect may reduce vertigo and tinnitus for some patients.
- H1 Action
- Promotes vasodilation in inner‑ear microcirculation
- H3 Action
- Modulates vestibular neurotransmitter release
Clinical Terms
Practical pharmacology notes for prescribers and pharmacists.
Oral tablets are available in 8 mg, 16 mg and 24 mg; dosing is typically two to three times daily.
Pharmacokinetic detail: absorption is variable and there are no widely cited major CYP‑mediated interactions in registries.
| Mechanism | Expected Clinical Effect | Monitoring Points |
|---|---|---|
| H1 Agonism / H3 Antagonism | Reduced vertigo frequency/intensity in some patients | Assess vertigo diary, watch for GI adverse effects and drowsiness |
Indications & Off‑Label Uses
Approved Indications By TGA
Who is betahistine authorised for in Australia?
Primary authorised indication is management of Ménière’s disease and vestibular vertigo for symptom control.
Prescriptions should follow specialist or GP guidance for dose and duration.
Off‑Label Uses In Australian Practice
Clinicians sometimes use betahistine outside formal indications with informed consent.
Off‑label uses include adjunctive therapy for migraine‑associated vertigo and persistent non‑specific dizziness, and as part of vestibular rehabilitation programmes.
- Approved: Ménière’s disease and vestibular vertigo — follow labelled dosing.
- Off‑label: migraine‑associated vertigo, chronic non‑specific dizziness — ensure documented informed consent and monitoring for efficacy and adverse effects.
Key Clinical Findings (2022–2026 Summary)
Clinicians often want a concise evidence snapshot before prescribing.
Recent international studies and systematic reviews between 2022 and 2026 show mixed results.
Some randomised trials and observational studies report symptomatic benefit in Ménière’s and vestibular vertigo, while other reviews note heterogeneity and occasional null findings.
The United States market previously withdrew betahistine amid debate over efficacy, while other regulators including the TGA maintain approval.
For clinical practice: weigh trial data against individual patient response and monitor outcomes over weeks to months.
| Year | Design | Population | Outcome | Clinical Takeaway |
|---|---|---|---|---|
| 2022–2026 | Systematic Reviews & RCTs (varied) | Adults With Ménière’s Or Vestibular Vertigo | Mixed Results; Heterogeneous Evidence | Consider trial evidence but monitor individual response; document outcomes |
Clinicians should consult up‑to‑date systematic reviews and local guidelines when deciding to prescribe.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Mechanism | Dosing | PBS Subsidy | Pros | Cons |
|---|---|---|---|---|---|
| Dimenhydrinate | Antihistamine/antiemetic | Varies; short‑term use | Varies | Effective for acute nausea/vertigo | Sedating, anticholinergic effects |
| Meclizine | Antihistamine | Once daily dosing common | Varies | Less frequent dosing | Can cause sedation; regional availability varies |
| Cinnarizine | Calcium channel blocker/antihistamine | Varies | Varies | Useful in some vestibular conditions | Sedation; regional availability differs |
Pros And Cons Checklist
- Consider efficacy evidence for the specific vertigo type (Ménière’s vs acute vestibular events).
- Check side‑effect profiles: sedation and anticholinergic effects are common with alternatives.
- Review interaction risk with patient comorbidities such as glaucoma or BPH.
- Factor in cost and PBS subsidy when advising patients.
Common Questions (Pharmacy FAQs)
Here are concise answers for routine pharmacy consultations.
- Can I take with other meds? — Review current medicines and check interactions with antihypertensives and CNS depressants.
- How long before it works? — Often several weeks; reassess at 4–12 weeks for response.
- Is it safe in breastfeeding? — Data are limited; weigh risks and benefits and consult the GP or specialist.
- What to do for side effects? — Stop and seek urgent care for severe allergic reactions; for mild GI upset, take with food and consult GP.
- Overdose action — seek urgent medical attention; large doses can cause vomiting and, rarely, convulsions.
Pharmacy counselling checklist: confirm diagnosis, review concomitant medicines, advise on safety and driving, provide written instructions and schedule follow-up.
Price & Access Comparison Table (Implementation Note)
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
Do patients want a price comparison? Provide transparent options but avoid publishing fixed prices without verification.
| Retailer | Product | Prescription Required | PBS Subsidy |
|---|---|---|---|
| Chemist Warehouse | Serc 16 mg / 24 mg | Yes | Check PBS Schedule |
| Priceline | Serc 16 mg / 24 mg | Yes | Check PBS Schedule |
| Local Pharmacy | Serc 16 mg / 24 mg | Yes | Check PBS Schedule |
| Online Pharmacy | Serc 16 mg / 24 mg | Yes | Check PBS Schedule |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm you have a valid prescription before ordering or calling.
- Check ARTG/PBS entries for the exact brand and strength.
- Call ahead to confirm stock levels at local pharmacies, especially in rural areas.
- Allow extra delivery time for rural and remote locations.
- Ask about generics or patient assistance programs if cost is an issue.
Registration & Regulation
TGA Approval
Is it legal to prescribe in Australia?
Betahistine is TGA‑registered for prescription use in Australia.
Clinicians should confirm ARTG listings for the specific branded or generic product before prescribing and check sponsor or importer details when necessary.
PBS Subsidy Details
PBS listing may differ by formulation, indication and strength; verify the PBS Schedule and any authority prescription requirements before advising patients.
- Check the ARTG for the product and sponsor details.
- Verify PBS entries and any authority conditions for subsidy.
- Record prescribing rationale and monitoring plans in the patient record.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
How should patients store tablets in hot, humid weather?
Store betahistine in its original container below about 25°C, protected from moisture and light.
In hot or humid Australian conditions, advise an indoor, cool and dry spot (not the bathroom or a car glovebox).
- Do not use the medicine after its expiry date.
- Keep out of reach of children and pets.
- Return unwanted or expired medicines to a pharmacy for safe disposal.
Cold‑Chain Handling For Pharmacies
Pharmacies do not need cold‑chain storage for betahistine.
Store stock at room temperature away from direct heat and moisture and rotate stock to control expiry.
- Pharmacy SOPs: store in a dry dispensary cupboard under 25°C.
- Pharmacy SOPs: provide clear written storage advice to patients at dispensing.
- Pharmacy SOPs: maintain inventory checks and contact suppliers if stock shortages arise.
Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)
Australian Pharmacist Counselling Style
Patients often want a simple one‑page summary to take home.
Confirm the diagnosis — differentiate Ménière’s disease from other causes of vertigo.
Explain the dosage regimen, expected timeline for effect (often weeks) and common side effects.
Warn about driving and workplace safety until tolerance is known.
Confirm pregnancy and breastfeeding status and advise accordingly.
- Counselling steps: provide written dosing instructions and a medication‑use plan.
- Counselling steps: offer adherence aids such as dose organisers or phone reminders.
- Counselling steps: communicate initiation of therapy to the GP and schedule follow-up.
One‑page handout template idea: diagnosis, dose schedule, common side effects, safety advice, when to seek help and pharmacist contact details.
Patient Advice From PBS And National Health Authorities
Advise patients to check PBS entries for subsidy and follow GP instructions for duration and monitoring.
Encourage reporting of adverse events to the TGA and keeping follow‑up appointments to assess efficacy.
Escalation criteria: severe or worsening vertigo, new neurological signs, severe allergic reaction or inability to tolerate side effects.
- Seek urgent review if vertigo is increasing in frequency or severity despite treatment.
- Refer to ENT or neurology if symptoms persist after an adequate trial or if red flags appear.
- Document all advice and any patient concerns in the pharmacy record.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Cairns | Queensland | 9-14 days |
| Townsville | Queensland | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Bendigo | Victoria | 14-21 days |